絞り込み

16546

広告

「"Balagula Y "[Author]」の検索結果

34件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Cryptococcus-like Changes in the Setting of Vasculitis.

Interleukin-17, Inflammation, and Cardiovascular Risk in Patients With Psoriasis.

Management of dermatologic toxicities associated with epidermal growth factor inhibitors (EGFRIs) and multikinase inhibitors (MKIs).

Quality of life in patients with dermatologic toxicities: Experience from the SERIES clinic.

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a setting of chemotherapy treatment: An assessment of FDA MedWatch database.

Risk of rash and stomatitis with temsirolimus, a mammalian target of rapamycin (mTOR) inhibitor: A meta-analysis.

Hand-foot skin reaction, an anticipated dermatologic toxicity to pazopanib, with an unexpected low incidence: A systematic review of literature and meta-analysis.

Folliculocentric cutaneous presentation of disseminated Candida krusei infection in a patient with acute myeloid leukemia.

Plaque-like syringoma with involvement of deep reticular dermis.

Dermoscopy of a clonal (inverted type A) nevus in a child.

The great imitator revisited: the spectrum of atypical cutaneous manifestations of secondary syphilis.

Early-onset mycosis fungoides among African American women: A single-institution study.

Circumscribed plantar hypokeratosis.

Regression of cutaneous invasive squamous cell carcinoma in a patient with chronic cutaneous graft versus host disease.

Synergism between mTOR pathway and Ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.

Life-threatening dermatologic adverse events in oncology.

Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic.

In Reply.

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

  1. 1
  2. 2
Sort by
※並べ替えは表示に時間がかかります